Contact
searchSearch
HMP Global

HIV PrEP

Featured Article

Study Finds Rising PrEP Use and Declining Costs Amid Shift to Generics
04/02/2025
Grace Taylor, MS, MA
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising...
04/02/2025
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care

Newsfeed

News
HIV Cases Rise Among Gay Latinos
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care
News
Machine Learning Models Identify Patients With Rheumatoid Arthritis At Risk for Treatment Nonadherence
03/20/2026
Lisa Kuhns, PhD, MD
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help clinicians pinpoint which older patients with rheumatoid arthritis are most likely to fall off therapy—before it happens.
Machine learning models may help...
03/20/2026
First Report Managed Care
Behind the Bill
States Push Back on Proposed 2027 Marketplace Rule
03/19/2026
Hannah Musick
A sweeping proposed Affordable Care Act (ACA) Marketplace rule for 2027 is drawing sharp pushback from states, setting up a high-stakes debate over coverage, affordability, and program integrity.
A sweeping proposed Affordable Care Act (ACA) Marketplace rule for 2027 is drawing sharp pushback from states, setting up a high-stakes debate over coverage, affordability, and program integrity.
A sweeping proposed Affordable...
03/19/2026
First Report Managed Care
News
Older Adult Data Underreported in DLBCL Registration Trials Worldwide
03/18/2026
Hannah Musick
A systematic review of diffuse large B-cell lymphoma (DLBCL) registration trials found that while most primary outcomes are reported for older adults, key data on secondary endpoints, toxicity, and quality of life remain largely missing,...
A systematic review of diffuse large B-cell lymphoma (DLBCL) registration trials found that while most primary outcomes are reported for older adults, key data on secondary endpoints, toxicity, and quality of life remain largely missing,...
A systematic review of diffuse...
03/18/2026
First Report Managed Care
News
Multidrug Therapy Has Redefined Kidney Protection in Diabetic Kidney Disease
03/18/2026
Lisa Kuhns, PhD, MD
Decades of clinical trials are reshaping diabetic kidney disease care, with combination therapies now delivering unprecedented gains in renal and cardiovascular outcomes.
Decades of clinical trials are reshaping diabetic kidney disease care, with combination therapies now delivering unprecedented gains in renal and cardiovascular outcomes.
Decades of clinical trials are...
03/18/2026
First Report Managed Care
News
Fixed-Duration Epcoritamab Plus R2 Shows Strong Outcomes in R/R Follicular Lymphoma
03/17/2026
Grace Taylor, MS, MA
Fixed-duration epcoritamab combined with rituximab plus lenalidomide (R2) delivers high complete response rates and durable remissions in relapsed or refractory (R/R) follicular lymphoma, according to a study published in Blood.
Fixed-duration epcoritamab combined with rituximab plus lenalidomide (R2) delivers high complete response rates and durable remissions in relapsed or refractory (R/R) follicular lymphoma, according to a study published in Blood.
Fixed-duration epcoritamab...
03/17/2026
First Report Managed Care
News
Bispecific Antibodies Expand Treatment Options for Relapsed or Refractory DLBCL in Practice
03/16/2026
Lisa Kuhns, PhD, MD
Bispecific antibodies are emerging as an effective, off-the-shelf option for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), with promising response rates and growing evidence that they can be delivered safely in community...
Bispecific antibodies are emerging as an effective, off-the-shelf option for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), with promising response rates and growing evidence that they can be delivered safely in community...
Bispecific antibodies are...
03/16/2026
First Report Managed Care
News
Semaglutide Promotes Fat Loss While Preserving Muscle Function in Severe Obesity
03/13/2026
Lisa Kuhns, PhD, MD
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests...
03/13/2026
First Report Managed Care
Behind the Bill
Senate Advances Bipartisan Health Care Cybersecurity and Resiliency Act
03/13/2026
Grace Taylor, MS, MA
A bipartisan Senate bill advancing toward floor consideration would mandate new cybersecurity standards under the Health Insurance Portability and Accountability Act, strengthen federal oversight, and expand breach transparency.
A bipartisan Senate bill advancing toward floor consideration would mandate new cybersecurity standards under the Health Insurance Portability and Accountability Act, strengthen federal oversight, and expand breach transparency.
A bipartisan Senate bill...
03/13/2026
First Report Managed Care
News
Single Bispecific Antibody Use May Reduce Costs and Streamline Lymphoma Care
03/12/2026
Lisa Kuhns, PhD, MD
A single bispecific antibody used across multiple lymphoma indications could save oncology practices hundreds of thousands of dollars and thousands of staff hours annually, according to a new mixed-methods analysis published in Future...
A single bispecific antibody used across multiple lymphoma indications could save oncology practices hundreds of thousands of dollars and thousands of staff hours annually, according to a new mixed-methods analysis published in Future...
A single bispecific antibody...
03/12/2026
First Report Managed Care
News
Epcoritamab Shows Superior Responses vs Chemoimmunotherapy in Relapsed Follicular Lymphoma
03/11/2026
Hannah Musick
In an indirect comparison of third-line or later follicular lymphoma, epcoritamab demonstrated significantly higher response rates vs chemoimmunotherapy and favorable safety compared with other bispecific antibodies.
In an indirect comparison of third-line or later follicular lymphoma, epcoritamab demonstrated significantly higher response rates vs chemoimmunotherapy and favorable safety compared with other bispecific antibodies.
In an indirect comparison of...
03/11/2026
First Report Managed Care

Insights

Headshot of Brian Mustanski, Northwestern University
Interview
Insurance Coverage, Relationship Status, Other Factors Linked to PrEP Reinitiation
04/14/2022
Maria Asimopoulos
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor...
04/14/2022
First Report Managed Care
Chris Beyrer
Podcasts
PrEP in the United States Faces Slow Uptake and Coverage Among Payers
06/30/2021
Julie Gould
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious...
06/30/2021
First Report Managed Care
Podcasts
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
01/25/2021
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO,...
01/25/2021
First Report Managed Care
Videos
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care

Related Content

Current Issue

Oct/Nov/Dec Volume 22, Issue 4, First Report Managed Care
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use